Journal of Clinical and Experimental Hepatology
Scope & Guideline
Transforming insights into impactful liver care.
Introduction
Aims and Scopes
- Clinical Research on Liver Diseases:
The journal emphasizes clinical studies that investigate the epidemiology, diagnosis, and management of liver diseases such as Hepatitis, Non-alcoholic Fatty Liver Disease (NAFLD), and Hepatocellular Carcinoma (HCC). - Transplantation Studies:
There is a strong focus on liver transplantation, including donor evaluation, transplantation techniques, surgical outcomes, and post-transplant complications. - Innovative Therapies and Biomarkers:
The journal includes research on emerging therapies, drug efficacy, and the identification of novel biomarkers for liver diseases, particularly in the context of personalized medicine. - Interventional Procedures:
Papers discussing various interventional procedures, including endoscopic and radiological techniques for managing liver diseases, are a core part of the journal’s scope. - Public Health and Epidemiology:
The journal addresses the public health implications of liver diseases, exploring epidemiological trends and health policies that affect liver health. - Basic and Translational Research:
It also covers experimental studies that provide insights into the pathophysiology of liver diseases, facilitating the translation of basic research findings into clinical applications.
Trending and Emerging
- Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD):
Recent publications indicate a growing focus on MAFLD, reflecting a shift from traditional NAFLD terminology and emphasizing the metabolic aspects of liver disease. - Advancements in Liver Transplantation Techniques:
There is an increasing number of studies exploring innovative techniques in liver transplantation, including living donor transplantation and the use of machine perfusion. - Artificial Intelligence and Machine Learning:
The application of AI and machine learning in diagnostic processes and treatment personalization is emerging as a significant trend, with several studies exploring its potential in hepatology. - Interventions in Hepatic Encephalopathy:
Research on new interventions for managing hepatic encephalopathy is trending, particularly studies examining dietary modifications and pharmacological approaches. - Public Health Initiatives and Screening Programs:
There is a notable increase in research focused on public health strategies, including screening and early intervention programs for high-risk populations, particularly for viral hepatitis. - Patient-Centric Outcomes and Quality of Life Assessments:
Studies investigating the impact of liver diseases on patients' quality of life and health-related outcomes are gaining prominence, reflecting a more holistic view of patient care.
Declining or Waning
- Traditional Pharmacological Therapies:
There has been a noticeable decline in papers focused solely on traditional pharmacological treatments for liver diseases, possibly due to the rise of novel therapies and personalized medicine approaches. - Single-Center Studies:
The prevalence of single-center studies appears to be waning as the journal increasingly emphasizes multicenter trials and large cohort studies that provide more generalizable data. - Basic Science without Clinical Application:
Research that does not connect basic science findings to clinical applications is becoming less common, indicating a shift towards studies that demonstrate direct relevance to patient care. - Outdated Diagnostic Techniques:
There seems to be a reduction in studies focusing on older diagnostic methods, as newer, more effective technologies gain traction in the field. - Secondary Liver Diseases:
Topics related to secondary liver diseases, such as those caused by less common infectious agents or rare genetic conditions, are becoming less frequent, likely overshadowed by more prevalent conditions.
Similar Journals
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Unveiling Breakthroughs in Gastrointestinal and Liver ScienceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Transforming gastroenterology with cutting-edge research.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.
International Journal of Hepatology
Pioneering insights for a healthier liver tomorrow.The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.
HEPATOLOGY
Championing excellence in liver research since 1981.HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.
WORLD JOURNAL OF GASTROENTEROLOGY
Championing high-quality studies in gastroenterology.WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.
JOURNAL OF HEPATOLOGY
Advancing Liver Health Through Pioneering ResearchJOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.
Hepatobiliary Surgery and Nutrition
Innovating hepatobiliary care for better patient outcomes.Hepatobiliary Surgery and Nutrition is a leading journal dedicated to advancing the fields of hepatobiliary surgery and nutritional science, published by AME Publishing Company. With a commitment to disseminate high-quality research, this journal serves as a vital platform for clinicians, researchers, and students alike to share their findings and insights related to liver and biliary health. The journal operates under an Open Access model, ensuring that cutting-edge research is readily available to a global audience. Although specific rankings and impact factors are currently not provided, the journal's focus on innovative surgical techniques and nutritional strategies underscores its importance in improving patient outcomes and shaping future practices in hepatobiliary medicine. Situated in Hong Kong, Hepatobiliary Surgery and Nutrition invites submissions that push the boundaries of knowledge in these crucial areas, fostering a collaborative environment for advancement in surgery and nutrition.
Clinical and Molecular Hepatology
Pioneering insights in hepatology and molecular biology.Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.
World Journal of Hepatology
Connecting global researchers to advance hepatology knowledge.World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.
Hepatology Forum
Illuminating the path to better liver health.Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.